long intergenic non-protein coding RNA 2120Genealiases: []
Q-omics provides the consensus-scored LINC02120 profile across patient tissues and cancer cell-line models. LINC02120 expression is associated with patient survival in 16 of 34 cancer types, with the highest sampling consensus in STAD. Among the 18 cancer types available for tumor–normal comparison, LINC02120 is differentially expressed in 8, with the highest sampling consensus in KIRP. Additionally, LINC02120 RNA expression shows 6,518 significant pathway-activity associations, with the highest sampling consensus in STAD. Together, these results highlight STAD, and KIRP as cancer lineages where LINC02120 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC02120 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC02120 survival associations across molecular data types. LINC02120 RNA expression shows survival associations in the most cancer types (16). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC02120 RNA expression–survival associations across cancer types. High LINC02120 expression shows unfavorable associations in UVM, KIRP, KICH, PAAD and BLCA, but favorable associations in STAD. The STAD Kaplan–Meier curve shows clear separation, with the low-expression group declining faster, consistent with the favorable association (log-rank p < 0.001). Together, the overview and detailed table identify STAD as the clearest survival context for LINC02120 RNA expression.
This table summarizes LINC02120 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 8. The strongest signals are observed in KIRP for RNA.
This table ranks reproducible tumor–normal expression differences for LINC02120. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC02120 shows lower tumor expression in KIRP and THCA and higher tumor expression in LUSC, HNSC, COAD and PRAD. The KIRP box plot shows higher LINC02120 RNA expression in normal versus tumor tissue (log2 FC = −0.064, t-test p = .011).
This table shows molecular features associated with LINC02120 in patient tissues and cancer cell lines. In patient samples, LINC02120 shows the broadest associations at the RNA and protein expression levels, with STAD recurring as the lineage with the largest associated feature set.
